Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus-Reference-Cited by-同舟云学术

Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus

Published:2020-08-14 Issue:10 Volume:40 Page:1717-1724
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Ilizaliturri-Guerra Octavio^ORCID,Uriarte-Botello Rodolfo^ORCID,Pineda-Sic Rita Ángelica^ORCID,Serna-Peña Griselda^ORCID,Garza-Elizondo Mario Alberto^ORCID,Galarza-Delgado Dionicio Ángel^ORCID,Leal-Bramasco Ana Sofía,Elizondo-Solís César Vidal^ORCID,Santoyo-Fexas Leticia^ORCID,Villarreal-Alarcón Miguel Ángel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00296-020-04668-4.pdf

Reference18 articles.

1. Bussel J (2006) Treatment of immune thrombocytopenic purpura in adults. Semin Hematol 43(3 Suppl 5):S3–S10. https://doi.org/10.1053/j.seminhematol.2006.04.009(discussion S18–S19)

2. Chen H, Zheng W, Su J, Xu D, Wang Q, Leng X, Zhang W, Li M, Tang F, Zhang X, Zeng X, Zhao Y, Zhang F (2011) Low-dose rituximab therapy for refractory thrombocytopenia in patients with systemic lupus erythematosus—a prospective pilot study. Rheumatology (Oxford) 50(9):1640–1644. https://doi.org/10.1093/rheumatology/ker176

3. Garcia-Carrasco M, Jimenez-Hernandez M, Escarcega RO, Mendoza-Pinto C, Galarza-Maldonado C, Sandoval-Cruz M, Zamudio-Huerta L, Lopez-Colombo A, Cervera R (2009) Use of rituximab in patients with systemic lupus erythematosus: an update. Autoimmun Rev 8(4):343–348. https://doi.org/10.1016/j.autrev.2008.11.006

4. Karpatkin S (1985) Autoimmune thrombocytopenic purpura. Semin Hematol 22(4):260–288

5. Lu TY, Ng KP, Cambridge G, Leandro MJ, Edwards JC, Ehrenstein M, Isenberg DA (2009) A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients. Arthritis Rheum 61(4):482–487. https://doi.org/10.1002/art.24341

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Description of therapeutic strategies in severe systemic lupus erythematosus-associated immune thrombocytopenia: a retrospective cohort study of response and relapse;Clinical Rheumatology;2024-06-25

2. Rituximab alleviates pediatric systemic lupus erythematosus associated refractory immune thrombocytopenia: a case-based review;Immunologic Research;2024-01-27

3. B cell repopulation trajectory after rituximab treatment in autoimmune diseases: a longitudinal observational study;Clinical and Experimental Medicine;2023-09-26

4. Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach;BMC Nephrology;2023-05-26

5. Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review;Frontiers in Medicine;2023-05-25